Eisaku Nakamura
Director/Miembro de la Junta en KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. .
Cargos activos de Eisaku Nakamura
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Miembro de la Junta | 01/03/2016 | - |
| Independent Dir/Board Member | 01/03/2016 | - | |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Director/Miembro de la Junta | 29/03/2018 | - |
| Independent Dir/Board Member | 29/03/2018 | - | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01/01/2017 | - |
| Director/Miembro de la Junta | 01/09/2013 | 01/01/2017 |
Historial de carrera de Eisaku Nakamura
Antiguos cargos conocidos de Eisaku Nakamura.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACUCELA INC | Director/Miembro de la Junta | 01/05/2015 | - |
Estadísticas
Internacional
| Japón | 4 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Bolsa de valores
- Insiders
- Eisaku Nakamura
- Experiencia
